Literature DB >> 35091670

Gut microbiota mediates the alleviative effect of polar lipids-enriched milk fat globule membrane on obesity-induced glucose metabolism disorders in peripheral tissues in rat dams.

Tiange Li1, Qichen Yuan1, Han Gong1, Min Du2, Xueying Mao3.   

Abstract

BACKGROUND: Obesity during pregnancy and lactation not only increases the incidence of metabolic disorders and gestational diabetes in mothers, but also programs adiposity and related metabolic diseases in offspring. The aim of this study was to investigate the effects of milk polar lipids on gut microbiota and glucose metabolism in high-fat diet (HFD)-fed rat dams.
METHODS: Sprague Dawley (SD) female rats were fed a HFD for 8 weeks to induce obesity, followed by HFD with or without oral administration of polar lipids-enriched milk fat globule membrane (MFGM-PL) at 400 mg/kg BW during pregnancy and lactation. At the end of lactation, fresh fecal samples of dams were collected, the gut microbiota was assessed, and the insulin-signaling protein expression in peripheral tissues (adipose tissue, liver and skeletal muscle) were measured.
RESULTS: MFGM-PL supplementation attenuated body weight gain, ameliorated serum lipid profiles and improved insulin sensitivity in obese dams at the end of lactation. 16 S rDNA sequencing revealed that MFGM-PL increased the community richness and diversity of gut microbiota. The composition of gut microbiota was also changed after MFGM-PL supplementation as shown by an increase in the ratio of Bacteroidetes/Firmicutes and the relative abundance of Akkermansia, as well as a decrease in the relative abundance of Ruminococcaceae. The functional prediction of microbial communities by PICRUSt analysis showed that there were 7 KEGG pathways related to carbohydrate metabolism changed after MFGM-PL supplementation to HFD dams, including glycolysis/gluconeogenesis and insulin signaling pathway. Furthermore, MFGM-PL improved insulin signaling in the peripheral tissues including liver, adipose tissue and skeletal muscle.
CONCLUSIONS: MFGM-PL supplementation during pregnancy and lactation improves the glucose metabolism disorders in HFD-induced obese dams, which may be linked to the regulation of gut microbiota induced by MFGM-PL.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35091670     DOI: 10.1038/s41366-021-01029-4

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.551


  47 in total

Review 1.  Obesity and diabetes in mothers and their children: can we stop the intergenerational cycle?

Authors:  Sharon J Herring; Emily Oken
Journal:  Curr Diab Rep       Date:  2011-02       Impact factor: 4.810

Review 2.  Maternal obesity and infant outcomes.

Authors:  Rikke Ruager-Martin; Matthew J Hyde; Neena Modi
Journal:  Early Hum Dev       Date:  2010-09-16       Impact factor: 2.079

3.  Estrogen Improves Insulin Sensitivity and Suppresses Gluconeogenesis via the Transcription Factor Foxo1.

Authors:  Hui Yan; Wangbao Yang; Fenghua Zhou; Xiaopeng Li; Quan Pan; Zheng Shen; Guichun Han; Annie Newell-Fugate; Yanan Tian; Ravikumar Majeti; Wenshe Liu; Yong Xu; Chaodong Wu; Kimberly Allred; Clinton Allred; Yuxiang Sun; Shaodong Guo
Journal:  Diabetes       Date:  2018-11-28       Impact factor: 9.461

Review 4.  Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis.

Authors:  M R Torloni; A P Betrán; B L Horta; M U Nakamura; A N Atallah; A F Moron; O Valente
Journal:  Obes Rev       Date:  2008-11-24       Impact factor: 9.213

Review 5.  Glycogen synthase kinase 3: more than a namesake.

Authors:  Geetha Vani Rayasam; Vamshi Krishna Tulasi; Reena Sodhi; Joseph Alex Davis; Abhijit Ray
Journal:  Br J Pharmacol       Date:  2009-03-04       Impact factor: 8.739

6.  Maternal obesity and risk of gestational diabetes mellitus.

Authors:  Susan Y Chu; William M Callaghan; Shin Y Kim; Christopher H Schmid; Joseph Lau; Lucinda J England; Patricia M Dietz
Journal:  Diabetes Care       Date:  2007-04-06       Impact factor: 19.112

Review 7.  The PI3K/AKT pathway in obesity and type 2 diabetes.

Authors:  Xingjun Huang; Guihua Liu; Jiao Guo; Zhengquan Su
Journal:  Int J Biol Sci       Date:  2018-08-06       Impact factor: 6.580

8.  Programming effects of maternal and gestational obesity on offspring metabolism and metabolic inflammation.

Authors:  E Chang; H Hafner; M Varghese; C Griffin; J Clemente; M Islam; Z Carlson; A Zhu; L Hak; S Abrishami; B Gregg; K Singer
Journal:  Sci Rep       Date:  2019-11-05       Impact factor: 4.379

Review 9.  Early life nutritional programming of obesity: mother-child cohort studies.

Authors:  Michael E Symonds; Michelle A Mendez; Helle Margrete Meltzer; Berthold Koletzko; Keith Godfrey; Stewart Forsyth; Eline M van der Beek
Journal:  Ann Nutr Metab       Date:  2013-02-05       Impact factor: 3.374

10.  Timing of maternal exposure to a high fat diet and development of obesity and hyperinsulinemia in male rat offspring: same metabolic phenotype, different developmental pathways?

Authors:  Graham J Howie; Deborah M Sloboda; Clare M Reynolds; Mark H Vickers
Journal:  J Nutr Metab       Date:  2013-05-13
View more
  2 in total

1.  Milk fat globule membrane supplementation to obese rats during pregnancy and lactation promotes neurodevelopment in offspring via modulating gut microbiota.

Authors:  Qichen Yuan; Han Gong; Min Du; Tiange Li; Xueying Mao
Journal:  Front Nutr       Date:  2022-08-15

Review 2.  Inflammatory Signatures of Maternal Obesity as Risk Factors for Neurodevelopmental Disorders: Role of Maternal Microbiota and Nutritional Intervention Strategies.

Authors:  Francesca Cirulli; Roberta De Simone; Chiara Musillo; Maria Antonietta Ajmone-Cat; Alessandra Berry
Journal:  Nutrients       Date:  2022-07-30       Impact factor: 6.706

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.